Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

1,918 public trials 364 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Completed

Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)

NCT03040999

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • UCLA Medical Center ( Site 0273) Los Angeles, California, United States
  • University of California San Francisco ( Site 0274) San Francisco, California, United States
  • St. Joseph Heritage Healthcare ( Site 0254) Santa Rosa, California, United States
  • Smilow Cancer Hospital at Yale New Haven ( Site 0256) New Haven, Connecticut, United States
View all 151 locations
View Trial Details
Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

NCT02989064

Conditions
Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Completed

A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface

NCT04752215

Conditions
Carcinoma, Colonic Diseases, Colorectal Neoplasms, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • HealthONE Denver, Colorado, United States
View all 14 locations
View Trial Details
Completed

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

NCT03082534

Conditions
Carcinoma, Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, +37 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • University of California Los Angeles Cancer Center Los Angeles, California, United States
  • University of Michigan Cancer Center Ann Arbor, Michigan, United States
  • Washington School of Medicine Cancer Center St Louis, Missouri, United States
View Trial Details

Related conditions